Pricing

CeleCor Therapeutics

0 followers

‌

CeleCor Therapeutics develops a RUC-4 novel small molecule inhibitor designed to be the first point of contact treatment for segment elevated myocardial infarction. The molecule inhibitor uses a thrombolytic agent for percutaneous coronary intervention that can be administered subcutaneously by auto... Read more

Industries

Biotechnology, Health Care

Headquarters

Del Mar, United States

Employees

Links

Org chart

Robert S. Hillman

Co-founder, President And CEO

Robert S. Hillman

Collapse

Barry S. Coller

Chair, Medical & SAB, Co-Founder

Chief Financial Officer

Corporate Counsel

Senior Director, Planning & Administration

Board & advisors

Director

Director

Advisor

John Maraganore

Advisor

Andrew Weisenfeld

Advisor

Advisor

Advisor

Gilles Montalescot

Board Member

Board Member

Board Member

C. Michael Gibson

Board Member

Advisor

Teams

Advisory Team

6 members

Leadership Team

3 members

Offices

Similar companies

ARS Pharmaceuticals

1 follower

Calico

6 followers

Watchmaker Genomics

3 followers

Tessera Therapeutics

2 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Immunome

2 followers

Ambience Healthcare

2 followers

EpiVax, Inc.

2 followers

Merck

232 followers

Generate Biomedicines

3 followers

Explore companies